Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 510

1.

Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy.

Boivin G, Kalambaden P, Faget J, Rusakiewicz S, Montay-Gruel P, Meylan E, Bourhis J, Lesec G, Vozenin MC.

Front Oncol. 2018 Jul 9;8:256. doi: 10.3389/fonc.2018.00256. eCollection 2018.

2.

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.

Geoffrois L, Martin L, De Raucourt D, Sun XS, Tao Y, Maingon P, Buffet J, Pointreau Y, Sire C, Tuchais C, Babin E, Coutte A, Rolland F, Kaminsky MC, Alfonsi M, Lapeyre M, Saliou M, Lafond C, Jadaud E, Gery B, Zawadi A, Tourani JM, Khoury C, Henry AR, Hasbini A, Guichard F, Borel C, Meert N, Guillet P, Calais MH, Garaud P, Bourhis J.

J Clin Oncol. 2018 Jul 17:JCO2017762591. doi: 10.1200/JCO.2017.76.2591. [Epub ahead of print]

PMID:
30016178
3.

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.

Avivi I, Arcaini L, Ferretti VV, Boumendil A, Finel H, Milone G, Zaja F, Liliana D, Musso M, Didier B, Bachy E, Wattad M, Nicolas-Virelizier E, Gramatzki M, Bourhis JH, Caillot D, Haenel A, Held G, Thieblemont C, Jindra P, Pohlreich D, Guilhot F, Kroschinsky F, Wahlin B, Scheid C, Ifrah N, Berthou C, Dreger P, Montoto S, Conconi A.

Br J Haematol. 2018 Jul 9. doi: 10.1111/bjh.15454. [Epub ahead of print]

PMID:
29984825
4.

Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.

Gilleece MH, Labopin M, Yakoub-Agha I, Volin L, Socié G, Ljungman P, Huynh A, Deconinck E, Wu D, Bourhis JH, Cahn JY, Polge E, Mohty M, Savani BN, Nagler A.

Am J Hematol. 2018 Jul 7. doi: 10.1002/ajh.25211. [Epub ahead of print]

PMID:
29981272
5.

Response to Spartalis et al.

Jumeau R, Ozsahin M, Moeckli R, Pruvot E, Bourhis J.

Radiother Oncol. 2018 Aug;128(2):388. doi: 10.1016/j.radonc.2018.06.015. Epub 2018 Jun 28. No abstract available.

PMID:
29961582
6.

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.

Tao Y, Auperin A, Sire C, Martin L, Khoury C, Maingon P, Bardet E, Kaminsky MC, Lapeyre M, Chatellier T, Alfonsi M, Pointreau Y, Jadaud E, Géry B, Zawadi A, Tourani JM, Laguerre B, Coutte A, Racadot S, Hasbini A, Malaurie E, Borel C, Meert N, Cornely A, Ollivier N, Casiraghi O, Sun XS, Bourhis J.

J Clin Oncol. 2018 Jun 7:JCO2017762518. doi: 10.1200/JCO.2017.76.2518. [Epub ahead of print]

PMID:
29878867
7.

The advantage of Flash radiotherapy confirmed in mini-pig and cat-cancer patients.

Vozenin MC, De Fornel P, Petersson K, Favaudon V, Jaccard M, Germond JF, Petit B, Burki M, Ferrand G, Patin D, Bouchaab H, Ozsahin M, Bochud F, Bailat C, Devauchelle P, Bourhis J.

Clin Cancer Res. 2018 Jun 6. pii: clincanres.3375.2017. doi: 10.1158/1078-0432.CCR-17-3375. [Epub ahead of print]

PMID:
29875213
8.

Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?

Robinson TM, Fuchs EJ, Zhang MJ, St Martin A, Labopin M, Keesler DA, Blaise D, Bashey A, Bourhis JH, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, McNiece IK, Rocha V, Romee R, Socie G, Yakoub-Agha I, Soiffer RJ, Eapen M, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research.

Blood Adv. 2018 Jun 12;2(11):1180-1186. doi: 10.1182/bloodadvances.2018018291.

9.

Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.

Tao Y, Faivre L, Laprie A, Boisselier P, Ferron C, Jung GM, Racadot S, Gery B, Even C, Breuskin I, Bourhis J, Janot F.

Radiother Oncol. 2018 May 18. pii: S0167-8140(18)30246-9. doi: 10.1016/j.radonc.2018.05.005. [Epub ahead of print]

PMID:
29784451
10.

Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.

Jumeau R, Ozsahin M, Schwitter J, Vallet V, Duclos F, Zeverino M, Moeckli R, Pruvot E, Bourhis J.

Radiother Oncol. 2018 Aug;128(2):189-191. doi: 10.1016/j.radonc.2018.04.025. Epub 2018 May 9.

PMID:
29753550
11.

Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, Blaise D, Arcese W, Sociè G, Bourhis JH, Van Lint MT, Bruno B, Huynh A, Santarone S, Deconinck E, Mohty M, Nagler A.

Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. Epub 2018 May 10.

12.

(18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.

Scher N, Castelli J, Depeursinge A, Bourhis J, Prior JO, Herrera FG, Ozsahin M.

Cancer Radiother. 2018 May;22(3):229-235. doi: 10.1016/j.canrad.2017.10.003. Epub 2018 Apr 9.

PMID:
29650390
13.

Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.

Sun XS, Michel C, Babin E, De Raucourt D, Péchery A, Gherga E, Géry B, Florescu C, Bourhis J, Thariat J.

Future Oncol. 2018 Apr;14(9):877-889. doi: 10.2217/fon-2017-0468. Epub 2018 Mar 26.

PMID:
29578359
14.

Persistence of Yellow Fever Immunization-Induced Antibodies in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Adler M, Lapierre V, Sakr R, Bourhis JH, Gachot B, Castilla-Llorente C, Wyplosz B.

J Infect Dis. 2018 May 5;217(11):1844-1845. doi: 10.1093/infdis/jiy050. No abstract available.

PMID:
29547928
15.

Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients.

De Bari B, Lestrade L, Franzetti-Pellanda A, Jumeau R, Biggiogero M, Kountouri M, Matzinger O, Miralbell R, Bourhis J, Ozsahin M, Zilli T.

J Cancer Res Clin Oncol. 2018 Apr;144(4):781-789. doi: 10.1007/s00432-018-2608-6. Epub 2018 Feb 13.

PMID:
29441419
16.

Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments.

Conrad M, Bolard G, Nowak M, De Bari B, Jeanneret-Sozzi W, Bourhis J, Germond JF, Bochud F, Moeckli R.

Z Med Phys. 2018 Feb 6. pii: S0939-3889(17)30118-6. doi: 10.1016/j.zemedi.2018.01.001. [Epub ahead of print]

PMID:
29426589
17.

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.

Garderet L, Iacobelli S, Koster L, Goldschmidt H, Johansson JE, Bourhis JH, Krejci M, Leleu X, Potter M, Blaise D, Koenecke C, Peschel C, Radocha J, Metzner B, Lenain P, Schäfer-Eckart K, Pohlreich D, Grasso M, Caillot D, Einsele H, Ladetto M, Schönland S, Kröger N.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1372-1378. doi: 10.1016/j.bbmt.2018.01.035. Epub 2018 Feb 3.

PMID:
29408334
18.

Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation.

Devillier R, Labopin M, Chevallier P, Ledoux MP, Socié G, Huynh A, Bourhis JH, Cahn JY, Roth-Guepin G, Mufti G, Desmier D, Michallet M, Fegueux N, Ciceri F, Baron F, Blaise D, Nagler A, Mohty M.

Bone Marrow Transplant. 2018 Apr;53(4):431-437. doi: 10.1038/s41409-017-0043-y. Epub 2018 Jan 12.

19.

Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.

Tao Y, Auperin A, Sire C, Martin M, Saliou MG, Bardet E, Sun XS, Chatellier T, Morand C, Cornely A, Angokai M, Di Rito A, Kichenin K, Blanchard P, D'Onofrio I, Bourhis J.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):590-595. doi: 10.1016/j.ijrobp.2017.07.019. Epub 2017 Jul 22.

PMID:
29280453
20.

Analysis of the treatment plan evaluation process in radiotherapy through eye tracking.

Kyroudi A, Petersson K, Ozsahin M, Bourhis J, Bochud F, Moeckli R.

Z Med Phys. 2017 Dec 21. pii: S0939-3889(17)30140-X. doi: 10.1016/j.zemedi.2017.11.002. [Epub ahead of print]

PMID:
29275899
21.

A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02).

Frikha M, Auperin A, Tao Y, Elloumi F, Toumi N, Blanchard P, Lang P, Sun S, Racadot S, Thariat J, Alfonsi M, Tuchais C, Cornely A, Moussa A, Guigay J, Daoud J, Bourhis J; GORTEC.

Ann Oncol. 2018 Mar 1;29(3):731-736. doi: 10.1093/annonc/mdx770.

PMID:
29236943
22.

Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Decroocq J, Itzykson R, Vigouroux S, Michallet M, Yakoub-Agha I, Huynh A, Beckerich F, Suarez F, Chevallier P, Nguyen-Quoc S, Ledoux MP, Clement L, Hicheri Y, Guillerm G, Cornillon J, Contentin N, Carre M, Maillard N, Mercier M, Mohty M, Beguin Y, Bourhis JH, Charbonnier A, Dauriac C, Bay JO, Blaise D, Deconinck E, Jubert C, Raus N, Peffault de Latour R, Dhedin N.

Am J Hematol. 2018 Mar;93(3):416-423. doi: 10.1002/ajh.25004. Epub 2018 Jan 8.

PMID:
29226497
23.

Structural analysis of the complex between influenza B nucleoprotein and human importin-α.

Labaronne A, Milles S, Donchet A, Jensen MR, Blackledge M, Bourhis JM, Ruigrok RWH, Crépin T.

Sci Rep. 2017 Dec 7;7(1):17164. doi: 10.1038/s41598-017-17458-z.

24.

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.

Craddock C, Versluis J, Labopin M, Socie G, Huynh A, Deconinck E, Volin L, Milpied N, Bourhis JH, Rambaldi A, Chevallier P, Blaise D, Manz M, Vellenga E, Vekemans MC, Maertens J, Passweg J, Vyas P, Schmid C, Löwenberg B, Ossenkoppele G, Mohty M, Cornelissen JJ, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON-SAKK.

J Intern Med. 2018 Apr;283(4):371-379. doi: 10.1111/joim.12720. Epub 2018 Jan 5.

PMID:
29214689
25.

High dose-per-pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use.

Jaccard M, Durán MT, Petersson K, Germond JF, Liger P, Vozenin MC, Bourhis J, Bochud F, Bailat C.

Med Phys. 2018 Feb;45(2):863-874. doi: 10.1002/mp.12713. Epub 2018 Jan 6.

PMID:
29206287
26.

Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.

Grégoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A, Eisbruch A, Feng M, Giralt J, Gupta T, Hamoir M, Helito JK, Hu C, Hunter K, Johansen J, Kaanders J, Laskar SG, Lee A, Maingon P, Mäkitie A, Micciche' F, Nicolai P, O'Sullivan B, Poitevin A, Porceddu S, Składowski K, Tribius S, Waldron J, Wee J, Yao M, Yom SS, Zimmermann F, Grau C.

Radiother Oncol. 2018 Jan;126(1):3-24. doi: 10.1016/j.radonc.2017.10.016. Epub 2017 Nov 24.

PMID:
29180076
27.

[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Pugnet G, Castilla-Llorente C, Puyade M, Terriou L, Badoglio M, Deligny C, Guillaume-Jugnot P, Labeyrie C, Benzidia I, Faivre H, Lansiaux P, Marjanovic Z, Bourhis JH, Faucher C, Furst S, Huynh A, Martin T, Vermersch P, Yakoub-Agha I, Farge D.

Bull Cancer. 2017 Dec;104(12S):S169-S180. doi: 10.1016/j.bulcan.2017.06.019. Epub 2017 Nov 22. Review. French.

PMID:
29173974
28.

A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.

Saleh K, Danu A, Koscielny S, Legoupil C, Pilorge S, Castilla-Llorente C, Ghez D, Lazarovici J, Michot JM, Khalife-Saleh N, Lapierre V, Alenxandrova K, Arfi-Rouche J, Bourhis JH, Ribrag V.

Leuk Lymphoma. 2017 Nov 22:1-8. doi: 10.1080/10428194.2017.1403019. [Epub ahead of print]

PMID:
29164977
29.

[Chimerism analysis after hematopoietic cell transplantation: Guidelines from the Francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].

Dubois V, Alizadeh M, Bourhis JH, Etancelin P, Farchi O, Ferrand C, Goursaud L, Mollet I, Renac V, Varlet P, Yakoub-Agha I, Bay JO.

Bull Cancer. 2017 Dec;104(12S):S59-S64. doi: 10.1016/j.bulcan.2017.08.010. Epub 2017 Nov 8. French.

PMID:
29128084
30.

Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features.

Hasmim M, Khalife N, Zhang Y, Doldur M, Visentin G, Terry S, Giron-Michel J, Tang R, Delhommeau F, Dulphy N, Bourhis JH, Louache F, Chouaib S.

Oncoimmunology. 2017 Jul 18;6(10):e1346763. doi: 10.1080/2162402X.2017.1346763. eCollection 2017.

31.

Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.

Paviglianiti A, Ruggeri A, Volt F, Sanz G, Milpied N, Furst S, Esquirol A, Arcese W, Picardi A, Ferra C, Ifrah N, Bourhis JH, Raj K, von dem Borne PA, Sica S, Menard AL, Bloor A, Kenzey C, Gluckman E, Rocha V.

Br J Haematol. 2017 Dec;179(5):790-801. doi: 10.1111/bjh.14962. Epub 2017 Oct 19.

PMID:
29048109
32.

[Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].

Blais E, Pichon B, Mampuya A, Antoine M, Lagarde P, Kantor G, Breton-Callu C, Lefebvre C, Gerard M, Aamarcha A, Ozsahin M, Bourhis J, Maingon P, Troussier I, Pourel N.

Cancer Radiother. 2017 Oct;21(6-7):584-596. doi: 10.1016/j.canrad.2017.07.046. Epub 2017 Sep 5. Review. French.

PMID:
28886981
33.

[Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)].

Biau J, Miroir J, Millardet C, Saroul N, Pham-Dang N, Racadot S, Huguet F, Kwiatkowski F, Pereira B, Bourhis J, Lapeyre M.

Cancer Radiother. 2017 Oct;21(6-7):527-532. doi: 10.1016/j.canrad.2017.07.033. Epub 2017 Aug 31. French.

PMID:
28865970
34.

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.

Lacas B, Bourhis J, Overgaard J, Zhang Q, Grégoire V, Nankivell M, Zackrisson B, Szutkowski Z, Suwiński R, Poulsen M, O'Sullivan B, Corvò R, Laskar SG, Fallai C, Yamazaki H, Dobrowsky W, Cho KH, Beadle B, Langendijk JA, Viegas CMP, Hay J, Lotayef M, Parmar MKB, Aupérin A, van Herpen C, Maingon P, Trotti AM, Grau C, Pignon JP, Blanchard P; MARCH Collaborative Group.

Lancet Oncol. 2017 Sep;18(9):1221-1237. doi: 10.1016/S1470-2045(17)30458-8. Epub 2017 Jul 27. Erratum in: Lancet Oncol. 2018 Apr;19(4):e184.

35.

Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.

Tao Y, Aupérin A, Graff P, Lapeyre M, Grégoire V, Maingon P, Geoffrois L, Verrelle P, Calais G, Gery B, Martin L, Alfonsi M, Deprez P, Bardet E, Pignon T, Rives M, Sire C, Bourhis J.

Oral Oncol. 2017 Aug;71:61-66. doi: 10.1016/j.oraloncology.2017.06.002. Epub 2017 Jun 9.

PMID:
28688693
36.

Chest-MRI under pulsatile flow ventilation: A new promising technique.

Beigelman-Aubry C, Peguret N, Stuber M, Delacoste J, Belmondo B, Lovis A, Simons J, Long O, Grant K, Berchier G, Rohner C, Bonanno G, Coppo S, Schwitter J, Ozsahin M, Qanadli S, Meuli R, Bourhis J.

PLoS One. 2017 Jun 12;12(6):e0178807. doi: 10.1371/journal.pone.0178807. eCollection 2017.

37.

Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s.

Montay-Gruel P, Petersson K, Jaccard M, Boivin G, Germond JF, Petit B, Doenlen R, Favaudon V, Bochud F, Bailat C, Bourhis J, Vozenin MC.

Radiother Oncol. 2017 Sep;124(3):365-369. doi: 10.1016/j.radonc.2017.05.003. Epub 2017 May 22.

PMID:
28545957
38.

Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin

Bukreyeva I, Angoulvant A, Bendib I, Gagnard JC, Bourhis JH, Dargère S, Bonhomme J, Thellier M, Gachot B, Wyplosz B.

Emerg Infect Dis. 2017 Jun;23(6):1039-1041. doi: 10.3201/eid2306.161825.

39.

Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.

Canaani J, Labopin M, Socié G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A.

Am J Hematol. 2017 Jul;92(7):653-659. doi: 10.1002/ajh.24737. Epub 2017 May 26.

40.

Prolonged Apnea Supported by High-Frequency Noninvasive Ventilation: A Pilot Study.

Ogna A, Bernasconi M, Belmondo B, Long O, Simons J, Peguret N, Heinzer R, Nicod LP, Bourhis J, Lovis A.

Am J Respir Crit Care Med. 2017 Apr 1;195(7):958-960. doi: 10.1164/rccm.201608-1572LE. No abstract available.

PMID:
28362201
41.

TAT-RasGAP317-326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death.

Tsoutsou P, Annibaldi A, Viertl D, Ollivier J, Buchegger F, Vozenin MC, Bourhis J, Widmann C, Matzinger O.

Radiat Res. 2017 May;187(5):562-569. doi: 10.1667/RR14509.1. Epub 2017 Mar 21.

PMID:
28323576
42.

Implementation of TomoEDGE in the independent dose calculator CheckTomo.

Schopfer M, Thomas SJ, Tudor GS, Bourhis J, Bochud F, Moeckli R.

J Appl Clin Med Phys. 2017 Mar;18(2):92-99. doi: 10.1002/acm2.12048. Epub 2017 Mar 6.

43.

Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?

Castelli J, Depeursinge A, de Bari B, Devillers A, de Crevoisier R, Bourhis J, Prior JO.

Clin Nucl Med. 2017 Jun;42(6):e281-e285. doi: 10.1097/RLU.0000000000001614.

PMID:
28288042
44.

[Hopes of high dose-rate radiotherapy].

Fouillade C, Favaudon V, Vozenin MC, Romeo PH, Bourhis J, Verrelle P, Devauchelle P, Patriarca A, Heinrich S, Mazal A, Dutreix M.

Bull Cancer. 2017 Apr;104(4):380-384. doi: 10.1016/j.bulcan.2017.01.012. Epub 2017 Mar 7. Review. French.

PMID:
28283183
45.

A PET-based nomogram for oropharyngeal cancers.

Castelli J, Depeursinge A, Ndoh V, Prior JO, Ozsahin M, Devillers A, Bouchaab H, Chajon E, de Crevoisier R, Scher N, Jegoux F, Laguerre B, De Bari B, Bourhis J.

Eur J Cancer. 2017 Apr;75:222-230. doi: 10.1016/j.ejca.2017.01.018. Epub 2017 Feb 24.

PMID:
28237868
46.

Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule.

Lestrade L, Zilli T, Kountouri M, Jumeau R, Matzinger O, Bourhis J, Miralbell R, Ozsahin M, De Bari B.

Clin Oncol (R Coll Radiol). 2017 Jul;29(7):e105-e109. doi: 10.1016/j.clon.2017.01.044. Epub 2017 Feb 20.

PMID:
28222958
47.

Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.

Morisod B, Venara-Vulpe II, Alzuphar S, Monnier Y, Bongiovanni M, Hagmann P, Bouchaab H, Bourhis J, Simon C.

Head Neck. 2017 May;39(5):965-973. doi: 10.1002/hed.24712. Epub 2017 Feb 11.

PMID:
28188953
48.

Commissioning of the Leksell Gamma Knife® Icon™.

Zeverino M, Jaccard M, Patin D, Ryckx N, Marguet M, Tuleasca C, Schiappacasse L, Bourhis J, Levivier M, Bochud FO, Moeckli R.

Med Phys. 2017 Feb;44(2):355-363. doi: 10.1002/mp.12052. Epub 2017 Jan 30.

PMID:
28133748
49.

How could breast cancer molecular features contribute to locoregional treatment decision making?

Tsoutsou PG, Vozenin MC, Durham AD, Bourhis J.

Crit Rev Oncol Hematol. 2017 Feb;110:43-48. doi: 10.1016/j.critrevonc.2016.12.006. Epub 2016 Dec 8. Review.

PMID:
28109404
50.

High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber.

Petersson K, Jaccard M, Germond JF, Buchillier T, Bochud F, Bourhis J, Vozenin MC, Bailat C.

Med Phys. 2017 Mar;44(3):1157-1167. doi: 10.1002/mp.12111. Epub 2017 Feb 28.

PMID:
28094853

Supplemental Content

Loading ...
Support Center